Analysis of adjudicated causes of death in a large cohort of Brazilian patients undergoing dialysis
Journal of Nephrology · 30.10.2026 · 39 (8) · 1626-1633
DOI: 10.1093/joneph/aajag152 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Nephrology, online erschienen am 14.08.2026. Verfasst von Cristiane de Magalhães Rosa Ribeiro und 4 weiteren Autor:innen. Beteiligte Einrichtung: Departamento médico, Fresenius Medical Care, Rio de Janeiro, RJ, Brasil. Hauptthemen laut MEDLINE: Renal Dialysis, Cardiovascular Diseases, Renal Insufficiency, Chronic. Die Arbeit nennt 30 Literaturangaben. Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico.
Abstract (Originalsprache)
Background
Patients with chronic kidney disease (CKD) undergoing dialysis have a high mortality risk. Cardiovascular and infectious events are the leading causes of death in this population; in Brazil, data on cause-specific mortality remain limited. Therefore, we analyzed the causes of death among patients treated within a national dialysis facility network.
Methods
This retrospective study evaluated adjudicated causes of death between 2022 and 2024 across 32 Fresenius Medical Care facilities. During monthly meetings, deaths occurring in the previous month were reviewed at each facility, in the presence of the local medical director, head nurse, and two physicians from the national headquarters.
Results
During the study period, 9763 patients underwent dialysis (96% hemodialysis/hemodiafiltration; 4% peritoneal dialysis). A total of 1994 deaths were recorded, of which 1742 were adjudicated and included in the analysis. At death, the median age was 72 years, 59% had diabetes, and the dialysis vintage was 37 months. Infection was the leading cause of death (41%), followed by cardiovascular disease (30%). Most deaths occurred in hospitals (84%), and only 2% in dialysis clinics; 52% were classified as unexpected. Compared with cardiovascular deaths, infection-related deaths occurred in older patients, more often in the hospital, and with longer hospital stays. Pneumonia (35%) and sudden death (37%) were the most common infection-related and cardiovascular causes, respectively.
Conclusion
In this large Brazilian dialysis cohort with adjudicated outcomes, infection was the leading cause of death, followed by cardiovascular disease. Structured, temporally framed mortality review meetings enabled systematic evaluation of deaths, contributing care processes, and patient safety.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Departamento médico, Fresenius Medical Care, Rio de Janeiro, RJ, Brasil.
- Universidade Federal Fluminense, Faculdade de Medicina, Programa de Pós-Graduação em Ciências Médicas, Niterói, RJ, Brasil.
- Disciplina de Nefrologia, Departamento de Medicine, Universidade Federal de São Paulo, São Paulo, SP, Brasil.
ORCID-Profile: Maria Eugenia Fernandes Canziani
Förderung
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
Zitieren
APA
Ribeiro, C. M. R., Strogoff-de-Matos, J. P., Barra, A. B. L., Canziani, M. E. F., & Fresenius Dialysis Group (2026). Analysis of adjudicated causes of death in a large cohort of Brazilian patients undergoing dialysis. Journal of Nephrology, 39(8), 1626-1633. https://doi.org/10.1093/joneph/aajag152
Vancouver
Ribeiro CMR, Strogoff-de-Matos JP, Barra ABL, Canziani MEF, Fresenius Dialysis Group. Analysis of adjudicated causes of death in a large cohort of Brazilian patients undergoing dialysis. Journal of Nephrology. 2026;39(8):1626-1633. doi:10.1093/joneph/aajag152
BibTeX
@article{Ribeiro2026,
author = {Ribeiro, Cristiane de Magalhães Rosa and Strogoff-de-Matos, Jorge Paulo and Barra, Ana Beatriz Lesqueves and Canziani, Maria Eugenia Fernandes and Fresenius Dialysis Group, Fresenius Dialysis Group},
title = {Analysis of adjudicated causes of death in a large cohort of Brazilian patients undergoing dialysis},
journal = {Journal of Nephrology},
year = {2026},
volume = {39},
number = {8},
pages = {1626--1633},
doi = {10.1093/joneph/aajag152}
}
EUVIMED